Caeli Nova provides a technology system intended for the medicine and aviation sectors.
Caeli Nova has raised $2.2M in total funding. The most recent round was Series A. The last funding was announced in February 2022.
Caeli Nova's investors include Latecoere, Armada Investment AG, Ornament Health, LG Capital.
Caeli Nova is headquartered in London, United Kingdom.
Caeli Nova provides a technology system intended for the medicine and aviation sectors.
Caeli Nova is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Caeli Nova — Funding & Investors." VCBacked, February 21, 2022, https://www.vcbacked.co/company/caeli-nova. Accessed September 29, 2026.
VCBacked. (2022). Caeli Nova — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/caeli-nova
{{cite web |title=Caeli Nova — Funding & Investors |url=https://www.vcbacked.co/company/caeli-nova |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated